» Articles » PMID: 23737785

Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors

Overview
Publisher Wiley
Specialty Oncology
Date 2013 Jun 6
PMID 23737785
Citations 538
Authors
Affiliations
Soon will be listed here.
Abstract

Background. In the last decades, thyroid cancer incidence has continuously and sharply increased all over the world. This review analyzes the possible reasons of this increase. Summary. Many experts believe that the increased incidence of thyroid cancer is apparent, because of the increased detection of small cancers in the preclinical stage. However, a true increase is also possible, as suggested by the observation that large tumors have also increased and gender differences and birth cohort effects are present. Moreover, thyroid cancer mortality, in spite of earlier diagnosis and better treatment, has not decreased but is rather increasing. Therefore, some environmental carcinogens in the industrialized lifestyle may have specifically affected the thyroid. Among potential carcinogens, the increased exposure to medical radiations is the most likely risk factor. Other factors specific for the thyroid like increased iodine intake and increased prevalence of chronic autoimmune thyroiditis cannot be excluded, while other factors like the increasing prevalence of obesity are not specific for the thyroid. Conclusions. The increased incidence of thyroid cancer is most likely due to a combination of an apparent increase due to more sensitive diagnostic procedures and of a true increase, a possible consequence of increased population exposure to radiation and to other still unrecognized carcinogens.

Citing Articles

Tracheal nodularity and paratracheal soft tissue nodule: post-radioactive iodine treatment changes with peculiar visual and pathologic findings in a case of metastatic follicular variant papillary thyroid carcinoma: a case report.

Sievers B, Shi W, Hu J, Miller R, Patel N, Van Nostrand K J Med Case Rep. 2025; 19(1):92.

PMID: 40033425 PMC: 11877761. DOI: 10.1186/s13256-025-05116-2.


Validation of a Compact and Self-Contained Pyrosequencing Platform for Clinical Screening of Mutations in Thyroid Cancers.

Burkhardt A, Smith C, Singh R Diagnostics (Basel). 2025; 15(3).

PMID: 39941320 PMC: 11817209. DOI: 10.3390/diagnostics15030390.


Circular RNAs in cancer.

Guo Y, Huang Q, Heng Y, Zhou Y, Chen H, Xu C MedComm (2020). 2025; 6(2):e70079.

PMID: 39901896 PMC: 11788016. DOI: 10.1002/mco2.70079.


A multivariable model of ultrasound and biochemical parameters for predicting high-volume lymph node metastases of papillary thyroid carcinoma with Hashimoto's thyroiditis.

Liu X, Yin H, Shen H, Wang X, Zhang Z, Yuan X Front Endocrinol (Lausanne). 2025; 15:1501142.

PMID: 39866732 PMC: 11757122. DOI: 10.3389/fendo.2024.1501142.


The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review.

Muntean C, Solomon A, Cipaian R, Vonica R, Butuca A, Gaborean V J Clin Med. 2025; 14(2.

PMID: 39860342 PMC: 11765571. DOI: 10.3390/jcm14020338.


References
1.
Sprague B, Andersen S, Trentham-Dietz A . Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control. 2008; 19(6):585-93. DOI: 10.1007/s10552-008-9122-0. View

2.
Romei C, Fugazzola L, Puxeddu E, Frasca F, Viola D, Muzza M . Modifications in the papillary thyroid cancer gene profile over the last 15 years. J Clin Endocrinol Metab. 2012; 97(9):E1758-65. DOI: 10.1210/jc.2012-1269. View

3.
Aschebrook-Kilfoy B, Ward M, Sabra M, Devesa S . Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid. 2010; 21(2):125-34. PMC: 3025182. DOI: 10.1089/thy.2010.0021. View

4.
Kilfoy B, Zheng T, Holford T, Han X, Ward M, Sjodin A . International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2008; 20(5):525-31. PMC: 2788231. DOI: 10.1007/s10552-008-9260-4. View

5.
Kent W, Hall S, Isotalo P, Houlden R, George R, Groome P . Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007; 177(11):1357-61. PMC: 2072986. DOI: 10.1503/cmaj.061730. View